^
    1year
    A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors (clinicaltrials.gov)
    P1, N=9, Recruiting, Shanghai Yunying Medical Technology
    New P1 trial
    |
    IFNG (Interferon, gamma) • IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • IL2 (Interleukin 2) • IL10 (Interleukin 10)
    |
    R130
    over1year
    A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=20, Recruiting, Shanghai Yunying Medical Technology
    New P1 trial • Oncolytic virus • IO biomarker • Metastases
    |
    IL6 (Interleukin 6) • CXCL8 (Chemokine (C-X-C motif) ligand 8) • IL2 (Interleukin 2) • IL10 (Interleukin 10) • IL4 (Interleukin 4)
    |
    R130
    over1year
    A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=24, Recruiting, Shanghai Yunying Medical Technology
    New P1 trial • Oncolytic virus • IO biomarker • Metastases
    |
    IL6 (Interleukin 6) • CXCL8 (Chemokine (C-X-C motif) ligand 8) • IL2 (Interleukin 2) • IL10 (Interleukin 10) • IL4 (Interleukin 4)
    |
    R130
    over1year
    A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=20, Recruiting, Shanghai Yunying Medical Technology
    New P1 trial • Oncolytic virus • IO biomarker • Metastases
    |
    IL6 (Interleukin 6) • CXCL8 (Chemokine (C-X-C motif) ligand 8) • IL2 (Interleukin 2) • IL10 (Interleukin 10) • IL4 (Interleukin 4)
    |
    R130
    over1year
    A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Bone and Soft Tissue Tumors (clinicaltrials.gov)
    P1, N=20, Recruiting, Shanghai Yunying Medical Technology
    New P1 trial
    |
    IL6 (Interleukin 6) • CXCL8 (Chemokine (C-X-C motif) ligand 8) • IL2 (Interleukin 2) • IL10 (Interleukin 10) • IL4 (Interleukin 4)
    |
    R130
    over1year
    A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck Cancer (clinicaltrials.gov)
    P1, N=9, Recruiting, Shanghai Yunying Medical Technology
    New P1 trial • Oncolytic virus • IO biomarker
    |
    IL6 (Interleukin 6) • CXCL8 (Chemokine (C-X-C motif) ligand 8) • IL2 (Interleukin 2) • IL10 (Interleukin 10) • IL4 (Interleukin 4)
    |
    R130